Q3 2021 Holdings
Filed 2021-11-15 | 57 holdings | $419.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $233.2M | 3,156,981 | 55.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $61.3M | 1,475,000 | 14.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $41.8M | 1,400,000 | 10.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $35.7M | 1,000,000 | 8.5% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $16.1M | 639,095 | 3.8% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $8.4M | 702,320 | 2.0% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $7.9M | 700,000 | 1.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.8M | 925,000 | 1.9% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $6.5M | 288,458 | 1.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $103.2K | 3,743,875 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $62.9K | 1,850,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $58.8K | 3,619,392 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $56.3K | 460,000 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $49.0K | 2,115,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $47.8K | 1,450,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $45.2K | 1,775,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $41.7K | 1,400,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $40.7K | 2,772,501 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $38.0K | 1,160,251 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $35.5K | 1,275,777 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $35.4K | 4,100,000 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $30.4K | 1,962,785 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $30.4K | 510,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $24.7K | 1,500,000 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $22.8K | 1,277,091 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $20.8K | 443,265 | 0.0% |
| Landos Biopharma Inc | COM | 515069102 | $20.5K | 1,405,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $19.8K | 1,206,308 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $17.9K | 1,069,545 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $17.7K | 1,003,394 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $17.4K | 1,855,812 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $14.9K | 2,000,000 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $12.5K | 400,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $12.3K | 500,000 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.8K | 681,812 | 0.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $8.3K | 1,339,793 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $8.0K | 1,000,000 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $7.3K | 1,175,000 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $6.9K | 507,923 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $6.6K | 465,331 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $6.4K | 324,333 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $4.8K | 247,122 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $4.6K | 1,500,000 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.5K | 425,000 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $4.1K | 200,000 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $3.8K | 299,853 | 0.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $2.8K | 52,069 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $2.7K | 134,650 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $2.2K | 200,493 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $2.2K | 94,345 | 0.0% |